Last reviewed · How we verify

inclisiran sodium injection — Competitive Intelligence Brief

inclisiran sodium injection (inclisiran sodium injection) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline.

marketed Small molecule Live · refreshed every 30 min

Target snapshot

inclisiran sodium injection (inclisiran sodium injection) — Novartis Pharmaceuticals.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
inclisiran sodium injection TARGET inclisiran sodium injection Novartis Pharmaceuticals marketed

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape

No sponsor landscape data.

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). inclisiran sodium injection — Competitive Intelligence Brief. https://druglandscape.com/ci/inclisiran-sodium-injection. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: